APM
Avidity Partners Management Portfolio holdings
AUM
$499M
1-Year Est. Return
3.47%
1 Year Est. Return
+3.47%
AUM
$485M
AUM Growth
-$518M
(-52%)
Holding
82
Top Buys
| 1 | +$13.9M | |
| 2 | +$10.9M | |
| 3 | +$10.8M | |
| 4 |
Organon & Co
OGN
|
+$7.97M |
| 5 |
State Street SPDR S&P Biotech ETF
XBI
|
+$7.62M |
Top Sells
| 1 | +$33.8M | |
| 2 | +$28.2M | |
| 3 | +$26.1M | |
| 4 |
Dianthus Therapeutics
DNTH
|
+$20.9M |
| 5 |
Kymera Therapeutics
KYMR
|
+$20.1M |
Sector Composition
| 1 | Healthcare | 98.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Neumora Therapeutics
NMRA
$452M
| – | – |
0
|
|
||
77
Oric Pharmaceuticals
ORIC
$1.19B
| – | – |
-1,265,200
|
|
||
78
Rocket Pharmaceuticals
RCKT
$355M
| – | – |
-1,053,300
|
|
||
79
Surgery Partners
SGRY
$2.82B
| – | – |
-514,200
|
|
||
80
Transmedics
TMDX
$4.18B
| – | – |
-192,400
|
|
||
|
ITCI
81
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| – | – |
-97,000
|
|
||
82
Acadia Healthcare
ACHC
$1.91B
| – | – |
-658,000
|
|